Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Recent progress and future options in the development of GLP-1 receptor agonists for the treatment of diabesity.

Lorenz M, Evers A, Wagner M.

Bioorg Med Chem Lett. 2013 Jul 15;23(14):4011-8. doi: 10.1016/j.bmcl.2013.05.022. Epub 2013 May 16. Review.

2.

An overview of once-weekly glucagon-like peptide-1 receptor agonists--available efficacy and safety data and perspectives for the future.

Madsbad S, Kielgast U, Asmar M, Deacon CF, Torekov SS, Holst JJ.

Diabetes Obes Metab. 2011 May;13(5):394-407. doi: 10.1111/j.1463-1326.2011.01357.x. Epub 2011 Jan 5. Review.

PMID:
21208359
3.

GLP-1 receptor agonists for type 2 diabetes mellitus: recent developments and emerging agents.

Trujillo JM, Nuffer W.

Pharmacotherapy. 2014 Nov;34(11):1174-86. doi: 10.1002/phar.1507. Review.

PMID:
25382096
4.

GLP-1R agonist therapy for diabetes: benefits and potential risks.

Samson SL, Garber A.

Curr Opin Endocrinol Diabetes Obes. 2013 Apr;20(2):87-97. doi: 10.1097/MED.0b013e32835edb32. Review.

PMID:
23403741
5.

Emerging new therapies for the treatment of type 2 diabetes mellitus: glucagon-like peptide-1 receptor agonists.

Lindamood CA, Taylor JR.

Clin Ther. 2015 Mar 1;37(3):483-93. doi: 10.1016/j.clinthera.2015.01.003. Epub 2015 Feb 4. Review.

PMID:
25659912
6.

Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Cardiac Disorders.

Wroge J, Williams NT.

Ann Pharmacother. 2016 Dec;50(12):1041-1050. Epub 2016 Aug 16. Review.

PMID:
27531946
7.

Clinical efficacy and safety of once-weekly glucagon-like peptide-1 agonists in development for treatment of type 2 diabetes mellitus in adults.

Tzefos M, Harris K, Brackett A.

Ann Pharmacother. 2012 Jan;46(1):68-78. doi: 10.1345/aph.1Q379. Review.

PMID:
22232377
8.
9.

A Plethora of GLP-1 Agonists: Decisions About What to Use and When.

Samson SL, Garber AJ.

Curr Diab Rep. 2016 Dec;16(12):120. Review.

PMID:
27766579
10.
11.

GLP-1 Agonists in Type 1 Diabetes Mellitus.

Janzen KM, Steuber TD, Nisly SA.

Ann Pharmacother. 2016 Aug;50(8):656-65. doi: 10.1177/1060028016651279. Epub 2016 Jun 1. Review.

PMID:
27252246
12.

Dulaglutide: the newest GLP-1 receptor agonist for the management of type 2 diabetes.

Thompson AM, Trujillo JM.

Ann Pharmacother. 2015 Mar;49(3):351-9. doi: 10.1177/1060028014564180. Epub 2015 Jan 6. Review.

PMID:
25565404
13.

[Dulaglutide and liraglutide compared].

Bruhn C.

Med Monatsschr Pharm. 2015 May;38(5):198-9. German. No abstract available.

PMID:
26364414
14.

Comparison of liraglutide versus other incretin-related anti-hyperglycaemic agents.

Blonde L, Montanya E.

Diabetes Obes Metab. 2012 Apr;14 Suppl 2:20-32. doi: 10.1111/j.1463-1326.2012.01575.x. Review.

PMID:
22405266
15.

Dulaglutide: first global approval.

Sanford M.

Drugs. 2014 Nov;74(17):2097-103. doi: 10.1007/s40265-014-0320-7. Review.

PMID:
25367716
16.

Beyond glucose lowering: glucagon-like peptide-1 receptor agonists, body weight and the cardiovascular system.

Verg├Ęs B, Bonnard C, Renard E.

Diabetes Metab. 2011 Dec;37(6):477-88. doi: 10.1016/j.diabet.2011.07.001. Epub 2011 Aug 25. Review.

PMID:
21871831
17.

Therapies for inter-relating diabetes and obesity - GLP-1 and obesity.

Iepsen EW, Torekov SS, Holst JJ.

Expert Opin Pharmacother. 2014 Dec;15(17):2487-500. doi: 10.1517/14656566.2014.965678. Epub 2014 Sep 26. Review. Erratum in: Expert Opin Pharmacother. 2015 Jan;16(1):147.

PMID:
25260877
18.

Efficacy and safety of once-weekly glucagon-like peptide 1 receptor agonists for the management of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.

Karagiannis T, Liakos A, Bekiari E, Athanasiadou E, Paschos P, Vasilakou D, Mainou M, Rika M, Boura P, Matthews DR, Tsapas A.

Diabetes Obes Metab. 2015 Nov;17(11):1065-74. doi: 10.1111/dom.12541. Epub 2015 Sep 23. Review.

PMID:
26395850
19.

Peptide-based GLP-1/glucagon co-agonists: A double-edged sword to combat diabesity.

Soni H.

Med Hypotheses. 2016 Oct;95:5-9. doi: 10.1016/j.mehy.2016.08.005. Epub 2016 Aug 12.

PMID:
27692167
20.

Supplemental Content

Support Center